|
US5545553A
(en)
*
|
1994-09-26 |
1996-08-13 |
The Rockefeller University |
Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them
|
|
US7153943B2
(en)
|
1997-07-14 |
2006-12-26 |
Bolder Biotechnology, Inc. |
Derivatives of growth hormone and related proteins, and methods of use thereof
|
|
US6753165B1
(en)
*
|
1999-01-14 |
2004-06-22 |
Bolder Biotechnology, Inc. |
Methods for making proteins containing free cysteine residues
|
|
US7270809B2
(en)
*
|
1997-07-14 |
2007-09-18 |
Bolder Biotechnology, Inc. |
Cysteine variants of alpha interferon-2
|
|
IL133974A0
(en)
*
|
1997-07-14 |
2001-04-30 |
Bolder Biotechnology Inc |
Derivatives of growth hormone and related proteins
|
|
US20080076706A1
(en)
|
1997-07-14 |
2008-03-27 |
Bolder Biotechnology, Inc. |
Derivatives of Growth Hormone and Related Proteins, and Methods of Use Thereof
|
|
US7495087B2
(en)
|
1997-07-14 |
2009-02-24 |
Bolder Biotechnology, Inc. |
Cysteine muteins in the C-D loop of human interleukin-11
|
|
US7378506B2
(en)
|
1997-07-21 |
2008-05-27 |
Ohio University |
Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
|
|
US6570062B1
(en)
*
|
1997-07-21 |
2003-05-27 |
Ohio University |
Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
|
|
US6639050B1
(en)
*
|
1997-07-21 |
2003-10-28 |
Ohio University |
Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
|
|
US6451986B1
(en)
*
|
1998-06-22 |
2002-09-17 |
Immunex Corporation |
Site specific protein modification
|
|
US20070212422A1
(en)
*
|
1999-11-10 |
2007-09-13 |
Manfred Keller |
Dry powder for inhalation
|
|
US6696063B1
(en)
*
|
1998-12-30 |
2004-02-24 |
Applied Research Systems Ars Holding N.V. |
Treatment of HIV-associated dysmorphia/dysmetabolic syndrome (HADDS) with or without lipodystrophy
|
|
AU2008202371B2
(en)
*
|
1999-01-14 |
2012-08-02 |
Bolder Biotechnology, Inc. |
Methods for making proteins containing free cysteine residues
|
|
US8288126B2
(en)
|
1999-01-14 |
2012-10-16 |
Bolder Biotechnology, Inc. |
Methods for making proteins containing free cysteine residues
|
|
US6946265B1
(en)
|
1999-05-12 |
2005-09-20 |
Xencor, Inc. |
Nucleic acids and proteins with growth hormone activity
|
|
AU5132900A
(en)
*
|
1999-05-12 |
2000-11-21 |
Xencor, Inc. |
Novel nucleic acids and proteins with growth hormone activity
|
|
AT408721B
(de)
|
1999-10-01 |
2002-02-25 |
Cistem Biotechnologies Gmbh |
Pharmazeutische zusammensetzung enthaltend ein antigen
|
|
WO2001025277A1
(en)
*
|
1999-10-07 |
2001-04-12 |
Maxygen Aps |
Single-chain antagonist polypeptides
|
|
DE10005301A1
(de)
*
|
2000-02-07 |
2001-08-09 |
Trutnau Hans Heinrich |
Multi-Schritt-Kinetik molekularer Interaktionen als analytisches Mess- und Auswerte-Verfahren
|
|
GB0011459D0
(en)
*
|
2000-05-12 |
2000-06-28 |
Univ Wales Medicine |
Sequences
|
|
WO2001085993A2
(en)
*
|
2000-05-12 |
2001-11-15 |
University Of Wales College Of Medicine |
Method for detecting growth hormone variations in humans, the variations and their uses
|
|
CN1318443C
(zh)
|
2000-05-16 |
2007-05-30 |
博尔德生物技术公司 |
含游离半胱氨酸残基的蛋白重折叠的方法
|
|
EP1290170A2
(en)
|
2000-06-16 |
2003-03-12 |
Asterion Limited |
Binding agents: chimeric ligand/receptor proteins
|
|
US8044259B2
(en)
|
2000-08-03 |
2011-10-25 |
The Regents Of The University Of Michigan |
Determining the capability of a test compound to affect solid tumor stem cells
|
|
US20080194022A1
(en)
*
|
2000-08-03 |
2008-08-14 |
Clarke Michael F |
Isolation and use of solid tumor stem cells
|
|
US6984522B2
(en)
*
|
2000-08-03 |
2006-01-10 |
Regents Of The University Of Michigan |
Isolation and use of solid tumor stem cells
|
|
KR20030038690A
(ko)
*
|
2000-08-07 |
2003-05-16 |
인헤일 테라퓨틱 시스템즈 인크. |
응집이 최소화된, 흡입성 분무 건조 4-나선 다발 단백질분말
|
|
AU2002213843B2
(en)
*
|
2000-11-10 |
2008-02-07 |
F. Hoffmann-La Roche Ltd. |
Apolipoprotein analogues
|
|
US20060183197A1
(en)
*
|
2001-01-11 |
2006-08-17 |
Andersen Kim V |
Variant growth hormone molecules conjugated with macromolecules compounds
|
|
WO2002055532A2
(en)
*
|
2001-01-11 |
2002-07-18 |
Maxygen Aps |
Variant growth hormone molecules conjugated with macromolecular compounds
|
|
US6867183B2
(en)
*
|
2001-02-15 |
2005-03-15 |
Nobex Corporation |
Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
|
|
US7060675B2
(en)
|
2001-02-15 |
2006-06-13 |
Nobex Corporation |
Methods of treating diabetes mellitus
|
|
US6835802B2
(en)
|
2001-06-04 |
2004-12-28 |
Nobex Corporation |
Methods of synthesizing substantially monodispersed mixtures of polymers having polyethylene glycol moieties
|
|
US6713452B2
(en)
|
2001-06-04 |
2004-03-30 |
Nobex Corporation |
Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
|
US6828305B2
(en)
*
|
2001-06-04 |
2004-12-07 |
Nobex Corporation |
Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
|
US6858580B2
(en)
*
|
2001-06-04 |
2005-02-22 |
Nobex Corporation |
Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
|
US7713932B2
(en)
|
2001-06-04 |
2010-05-11 |
Biocon Limited |
Calcitonin drug-oligomer conjugates, and uses thereof
|
|
US6828297B2
(en)
*
|
2001-06-04 |
2004-12-07 |
Nobex Corporation |
Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
|
CA2449647A1
(en)
*
|
2001-06-05 |
2002-12-12 |
Auckland Uniservices Limited |
Methods and compositions for assessment of pulmonary function and disorders
|
|
US7521175B2
(en)
|
2001-06-14 |
2009-04-21 |
The Regents Of The University Of California |
Mutations in the Bcr-Abl tyrosine kinase associated with resistance to STI-571
|
|
US7196059B2
(en)
*
|
2001-09-07 |
2007-03-27 |
Biocon Limited |
Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
|
|
CA2461292A1
(en)
|
2001-10-02 |
2003-04-10 |
Genentech, Inc. |
Apo-2 ligand variants and uses thereof
|
|
US6908963B2
(en)
*
|
2001-10-09 |
2005-06-21 |
Nektar Therapeutics Al, Corporation |
Thioester polymer derivatives and method of modifying the N-terminus of a polypeptide therewith
|
|
US8008252B2
(en)
|
2001-10-10 |
2011-08-30 |
Novo Nordisk A/S |
Factor VII: remodeling and glycoconjugation of Factor VII
|
|
US7173003B2
(en)
|
2001-10-10 |
2007-02-06 |
Neose Technologies, Inc. |
Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
|
|
EP2305312B1
(en)
*
|
2001-10-10 |
2015-03-04 |
ratiopharm GmbH |
Remodelling and glycoconjugation of follicle-stimulating hormone (FSH)
|
|
US7214660B2
(en)
|
2001-10-10 |
2007-05-08 |
Neose Technologies, Inc. |
Erythropoietin: remodeling and glycoconjugation of erythropoietin
|
|
US7179617B2
(en)
*
|
2001-10-10 |
2007-02-20 |
Neose Technologies, Inc. |
Factor IX: remolding and glycoconjugation of Factor IX
|
|
US7696163B2
(en)
|
2001-10-10 |
2010-04-13 |
Novo Nordisk A/S |
Erythropoietin: remodeling and glycoconjugation of erythropoietin
|
|
US7795210B2
(en)
|
2001-10-10 |
2010-09-14 |
Novo Nordisk A/S |
Protein remodeling methods and proteins/peptides produced by the methods
|
|
US7157277B2
(en)
|
2001-11-28 |
2007-01-02 |
Neose Technologies, Inc. |
Factor VIII remodeling and glycoconjugation of Factor VIII
|
|
US7399613B2
(en)
*
|
2001-10-10 |
2008-07-15 |
Neose Technologies, Inc. |
Sialic acid nucleotide sugars
|
|
US20040161802A1
(en)
*
|
2001-10-30 |
2004-08-19 |
Applied Molecular Evolution |
Methods for producing and improving therapeutic potency of binding polypeptides
|
|
MXPA04004291A
(es)
*
|
2001-11-09 |
2004-08-11 |
Upjohn Co |
Polimorfismos de un unico nucleotido en la gh-1.
|
|
EP1444262A2
(en)
*
|
2001-11-12 |
2004-08-11 |
University of Wales College of Medicine |
Growth hormone variations in humans and their uses
|
|
HRP20040448A2
(en)
*
|
2001-11-20 |
2006-02-28 |
Pharmacia Corporation |
Method for detecting cells with numerical chromosomal abnormalities
|
|
US20030171285A1
(en)
*
|
2001-11-20 |
2003-09-11 |
Finn Rory F. |
Chemically-modified human growth hormone conjugates
|
|
US7473680B2
(en)
|
2001-11-28 |
2009-01-06 |
Neose Technologies, Inc. |
Remodeling and glycoconjugation of peptides
|
|
GB2389115B
(en)
*
|
2001-12-14 |
2005-03-16 |
Asterion Ltd |
Polypeptide having a plurality of modified growth hormone receptor binding domains of growth hormone
|
|
RU2216346C1
(ru)
*
|
2002-06-10 |
2003-11-20 |
Семенова Наталья Викторовна |
Средство и способ для биогенной стимуляции организма
|
|
US7601688B2
(en)
|
2002-06-13 |
2009-10-13 |
Biocon Limited |
Methods of reducing hypoglycemic episodes in the treatment of diabetes mellitus
|
|
MXPA04012496A
(es)
|
2002-06-21 |
2005-09-12 |
Novo Nordisk Healthcare Ag |
Glicoformos del factor vii pegilados.
|
|
JP4574350B2
(ja)
|
2002-06-24 |
2010-11-04 |
ジェネンテック， インコーポレイテッド |
Ａｐｏ−２リガンド／ｔｒａｉｌ変異体とその使用法
|
|
US20040048315A1
(en)
*
|
2002-08-28 |
2004-03-11 |
Pharmacia Corporation |
Method for the preparation of growth hormone and antagonist thereof having lower levels of isoform impurities thereof
|
|
US20040121407A1
(en)
*
|
2002-09-06 |
2004-06-24 |
Elixir Pharmaceuticals, Inc. |
Regulation of the growth hormone/IGF-1 axis
|
|
DE60332358D1
(de)
*
|
2002-09-09 |
2010-06-10 |
Hanall Pharmaceutical Co Ltd |
Protease-resistente modifizierte interferon alpha polypeptide
|
|
DE60330787D1
(de)
*
|
2002-09-20 |
2010-02-11 |
Pharmacia Corp |
Verfahren zur verringerung der aggregatmengen des pegylierten proteins
|
|
US7470779B2
(en)
*
|
2002-09-20 |
2008-12-30 |
Pfizer Inc. |
Process for decreasing aggregate levels of pegylated protein
|
|
PA8588901A1
(es)
*
|
2002-11-20 |
2005-02-04 |
Pharmacia Corp |
Conjugados de hormona de crecimiento humana pegilados n-terminales y proceso para su preparacion
|
|
NZ525314A
(en)
*
|
2002-12-19 |
2005-02-25 |
Univ Cardiff |
Method and kit for diagnosing growth hormone dysfunction by determining SNP haplotypes of the proximal promoter region of the gene GH1
|
|
DK1581251T3
(da)
*
|
2002-12-31 |
2016-06-27 |
Althea Tech Inc |
Krystaller af humant væksthormon og fremgangsmåder til fremstilling deraf
|
|
CN102212019B
(zh)
|
2003-03-14 |
2015-05-27 |
蔚所番有限公司 |
支化水溶性聚合物及其缀合物
|
|
WO2004090135A2
(en)
*
|
2003-04-09 |
2004-10-21 |
Asterion Limited |
Cytokine polypeptides and antibodies containing a signal sequence for the attachement of glycosylphosphatidylinositol
|
|
US8791070B2
(en)
|
2003-04-09 |
2014-07-29 |
Novo Nordisk A/S |
Glycopegylated factor IX
|
|
WO2006127896A2
(en)
*
|
2005-05-25 |
2006-11-30 |
Neose Technologies, Inc. |
Glycopegylated factor ix
|
|
EP1615945B1
(en)
*
|
2003-04-09 |
2011-09-28 |
BioGeneriX AG |
Glycopegylation methods and proteins/peptides produced by the methods
|
|
WO2004091499A2
(en)
*
|
2003-04-09 |
2004-10-28 |
Neose Technologies, Inc. |
Intracellular formation of peptide conjugates
|
|
US20060252120A1
(en)
*
|
2003-05-09 |
2006-11-09 |
Kieliszewski Marcia J |
Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
|
|
MXPA05011832A
(es)
|
2003-05-09 |
2006-02-17 |
Neose Technologies Inc |
Composiciones y metodos para la preparacion de mutantes de glicosilacion de la hormona de crecimiento humano.
|
|
EP2003196A3
(en)
*
|
2003-06-09 |
2009-01-07 |
The Regents of the University of Michigan |
Compositions and methods for treating and diagnosing cancer
|
|
GB0315182D0
(en)
*
|
2003-06-28 |
2003-08-06 |
Asterion Ltd |
Cytokine variant polypeptides
|
|
WO2005012484A2
(en)
|
2003-07-25 |
2005-02-10 |
Neose Technologies, Inc. |
Antibody-toxin conjugates
|
|
GB0326632D0
(en)
|
2003-11-14 |
2003-12-17 |
Jagotec Ag |
Dry powder formulations
|
|
AU2004293103C1
(en)
*
|
2003-11-24 |
2010-12-02 |
Ratiopharm Gmbh |
Glycopegylated erythropoietin
|
|
US8633157B2
(en)
|
2003-11-24 |
2014-01-21 |
Novo Nordisk A/S |
Glycopegylated erythropoietin
|
|
US20080305992A1
(en)
*
|
2003-11-24 |
2008-12-11 |
Neose Technologies, Inc. |
Glycopegylated erythropoietin
|
|
EP1694274B1
(en)
*
|
2003-12-03 |
2013-04-24 |
BioGeneriX AG |
Glycopegylated granulocyte colony stimulating factor
|
|
US7956032B2
(en)
*
|
2003-12-03 |
2011-06-07 |
Novo Nordisk A/S |
Glycopegylated granulocyte colony stimulating factor
|
|
US20080318850A1
(en)
*
|
2003-12-03 |
2008-12-25 |
Neose Technologies, Inc. |
Glycopegylated Factor Ix
|
|
US20060040856A1
(en)
*
|
2003-12-03 |
2006-02-23 |
Neose Technologies, Inc. |
Glycopegylated factor IX
|
|
US8361961B2
(en)
|
2004-01-08 |
2013-01-29 |
Biogenerix Ag |
O-linked glycosylation of peptides
|
|
NZ548513A
(en)
*
|
2004-01-14 |
2010-05-28 |
Univ Ohio |
Methods of producing peptides/proteins in plants and peptides/proteins produced thereby
|
|
EP2368579A1
(en)
|
2004-01-21 |
2011-09-28 |
Novo Nordisk Health Care AG |
Transglutaminase mediated conjugation of peptides
|
|
US8778880B2
(en)
*
|
2004-02-02 |
2014-07-15 |
Ambrx, Inc. |
Human growth hormone modified at position 35
|
|
WO2005074633A2
(en)
*
|
2004-02-03 |
2005-08-18 |
The Regents Of The University Of Michigan |
Compositions and methods for characterizing, regulating, diagnosing, and treating cancer
|
|
EP1715895A2
(en)
*
|
2004-02-09 |
2006-11-02 |
Pharmacia Corporation |
Chemically-modified human growth hormone receptor antagonist conjugates
|
|
US20100028995A1
(en)
*
|
2004-02-23 |
2010-02-04 |
Anaphore, Inc. |
Tetranectin Trimerizing Polypeptides
|
|
CA2573918A1
(en)
|
2004-04-19 |
2005-11-24 |
Ohio University |
Cross-linkable glycoproteins and methods of making the same
|
|
EP1751115A4
(en)
|
2004-05-23 |
2010-10-20 |
Gerard M Housey |
THERAMUTEINMODULATOREN
|
|
CA2558760A1
(en)
*
|
2004-06-23 |
2006-01-05 |
Usv Limited |
Chimeric human growth hormone derived from the placenta and pituitary isoform and processes for obtaining said chimera
|
|
US8124653B2
(en)
|
2004-06-25 |
2012-02-28 |
The Board Of Regents Of The University Of Texas System |
Methods and compositions for the treatment of attention deficit hyperactivity disorder and hyperphenylalanemia
|
|
WO2006010143A2
(en)
|
2004-07-13 |
2006-01-26 |
Neose Technologies, Inc. |
Branched peg remodeling and glycosylation of glucagon-like peptide-1 [glp-1]
|
|
MX2007000883A
(es)
|
2004-07-19 |
2007-04-02 |
Biocon Ltd |
Conjugados de insulina-oligomero, formulaciones y usos de los mismos.
|
|
WO2006010891A2
(en)
*
|
2004-07-26 |
2006-02-02 |
Asterion Limited |
Linkers
|
|
US7597884B2
(en)
|
2004-08-09 |
2009-10-06 |
Alios Biopharma, Inc. |
Hyperglycosylated polypeptide variants and methods of use
|
|
EP1799249A2
(en)
|
2004-09-10 |
2007-06-27 |
Neose Technologies, Inc. |
Glycopegylated interferon alpha
|
|
WO2006042848A2
(en)
*
|
2004-10-18 |
2006-04-27 |
Novo Nordisk A/S |
Growth hormone conjugates
|
|
EP1814573B1
(en)
*
|
2004-10-29 |
2016-03-09 |
ratiopharm GmbH |
Remodeling and glycopegylation of fibroblast growth factor (fgf)
|
|
US7998930B2
(en)
|
2004-11-04 |
2011-08-16 |
Hanall Biopharma Co., Ltd. |
Modified growth hormones
|
|
JP5110880B2
(ja)
*
|
2004-11-18 |
2012-12-26 |
テルモ株式会社 |
医薬組成物、製剤および組み合わせ製剤
|
|
WO2006071840A2
(en)
*
|
2004-12-22 |
2006-07-06 |
Ambrx, Inc. |
Formulations of human growth hormone comprising a non-naturally encoded amino acid
|
|
US8080391B2
(en)
|
2004-12-22 |
2011-12-20 |
Ambrx, Inc. |
Process of producing non-naturally encoded amino acid containing high conjugated to a water soluble polymer
|
|
EP2284191A3
(en)
*
|
2004-12-22 |
2011-07-20 |
Ambrx, Inc. |
Process for the preparation of hGH
|
|
US20100009902A1
(en)
*
|
2005-01-06 |
2010-01-14 |
Neose Technologies, Inc. |
Glycoconjugation Using Saccharyl Fragments
|
|
CA2593682C
(en)
|
2005-01-10 |
2016-03-22 |
Neose Technologies, Inc. |
Glycopegylated granulocyte colony stimulating factor
|
|
US20060188498A1
(en)
|
2005-02-18 |
2006-08-24 |
Genentech, Inc. |
Methods of using death receptor agonists and EGFR inhibitors
|
|
EP1861125A2
(en)
*
|
2005-03-23 |
2007-12-05 |
Nektar Therapeutics Al, Corporation |
Conjugates of an hgh moiety and peg derivatives
|
|
WO2006102542A2
(en)
*
|
2005-03-23 |
2006-09-28 |
Bio-Rad Laboratories, Inc. |
Diverse chemical libraries bound to small particles with paramagnetic properties
|
|
US20090247421A1
(en)
*
|
2005-03-23 |
2009-10-01 |
Egisto Boschetti |
Diverse chemical libraries bound to small particles with paramagnetic properties
|
|
JP4841618B2
(ja)
*
|
2005-03-23 |
2011-12-21 |
バイオ−ラッド ラボラトリーズ インコーポレーティッド |
タンパク質を精製するための方法
|
|
EP1866427A4
(en)
*
|
2005-03-30 |
2010-09-01 |
Novo Nordisk As |
METHOD OF MANUFACTURING PEPTIDES PRODUCED IN INSECT CELL LINES
|
|
EP1871795A4
(en)
*
|
2005-04-08 |
2010-03-31 |
Biogenerix Ag |
COMPOSITIONS AND METHOD FOR PRODUCING GLYCOSYLATION MUTANTS OF A PROTEASE-RESISTANT HUMAN GROWTH HORMONE
|
|
CN101163505A
(zh)
*
|
2005-04-13 |
2008-04-16 |
伊拉斯谟大学鹿特丹医药中心 |
使用gh拮抗剂和生长抑素激动剂的治疗方法
|
|
EP1896607A4
(en)
*
|
2005-05-10 |
2009-12-16 |
Synergenz Bioscience Ltd |
METHOD AND COMPOSITIONS FOR THE ASSESSMENT OF LUNG FUNCTION AND RESPIRATORY DISEASE
|
|
MX2007014220A
(es)
*
|
2005-05-19 |
2009-02-16 |
Synergenz Bioscience Ltd |
Metodos para la valoracion del riesgo de desarrollar cancer de pulmon usando un analisis de polimorfismos geneticos.
|
|
EP1888779A4
(en)
*
|
2005-05-20 |
2009-06-10 |
Synergenz Bioscience Ltd |
METHOD FOR THE ANALYSIS OF POLYMORPHISMS AND USES THEREOF
|
|
US8431110B2
(en)
*
|
2005-05-23 |
2013-04-30 |
Hmi Medical Innovations, Llc. |
Compounds and method of identifying, synthesizing, optimizing and profiling protein modulators
|
|
EP1888098A2
(en)
|
2005-05-25 |
2008-02-20 |
Neose Technologies, Inc. |
Glycopegylated erythropoietin formulations
|
|
JP2008543855A
(ja)
|
2005-06-13 |
2008-12-04 |
ライジェル ファーマシューティカルズ， インコーポレイテッド |
変形性骨疾患を処置するための方法および組成物
|
|
US20070099209A1
(en)
*
|
2005-06-13 |
2007-05-03 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing cancer
|
|
WO2007008708A2
(en)
*
|
2005-07-08 |
2007-01-18 |
Ohio University |
Methods of predicting hyp-glycosylation sites for proteins expressed and secreted in plant cells, and related methods and products
|
|
US20090305967A1
(en)
*
|
2005-08-19 |
2009-12-10 |
Novo Nordisk A/S |
Glycopegylated factor vii and factor viia
|
|
US20070105755A1
(en)
|
2005-10-26 |
2007-05-10 |
Neose Technologies, Inc. |
One pot desialylation and glycopegylation of therapeutic peptides
|
|
US7855279B2
(en)
|
2005-09-27 |
2010-12-21 |
Amunix Operating, Inc. |
Unstructured recombinant polymers and uses thereof
|
|
WO2007041614A2
(en)
*
|
2005-10-03 |
2007-04-12 |
Bolder Biotechnology, Inc. |
Long acting vegf inhibitors and methods of use
|
|
PT2500360E
(pt)
|
2005-10-31 |
2015-10-15 |
Oncomed Pharm Inc |
Composições e métodos para diagnóstico e tratamento do cancro
|
|
US7723477B2
(en)
|
2005-10-31 |
2010-05-25 |
Oncomed Pharmaceuticals, Inc. |
Compositions and methods for inhibiting Wnt-dependent solid tumor cell growth
|
|
US7723112B2
(en)
*
|
2005-10-31 |
2010-05-25 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing cancer
|
|
WO2007056191A2
(en)
|
2005-11-03 |
2007-05-18 |
Neose Technologies, Inc. |
Nucleotide sugar purification using membranes
|
|
WO2007062213A2
(en)
|
2005-11-23 |
2007-05-31 |
Housey Pharmaceuticals Inc |
Compounds and methods of identifying, synthesizing, optimizing and profiling protein modulators
|
|
US8841255B2
(en)
|
2005-12-20 |
2014-09-23 |
Duke University |
Therapeutic agents comprising fusions of vasoactive intestinal peptide and elastic peptides
|
|
US20130172274A1
(en)
|
2005-12-20 |
2013-07-04 |
Duke University |
Methods and compositions for delivering active agents with enhanced pharmacological properties
|
|
JP2009521486A
(ja)
*
|
2005-12-23 |
2009-06-04 |
アルタス ファーマシューティカルズ インコーポレイテッド |
ポリカチオン錯化タンパク質結晶を含む組成物およびこれを使用した治療法
|
|
GB0602897D0
(en)
*
|
2006-02-13 |
2006-03-22 |
Jagotec Ag |
Improvements In Or Relating To Dry Powder Inhaler Devices
|
|
WO2007100640A2
(en)
*
|
2006-02-21 |
2007-09-07 |
The Regents Of The University Of Michigan |
Growth hormone receptor antagonist cancer treatment
|
|
GB0606946D0
(en)
*
|
2006-04-06 |
2006-05-17 |
Asterion Ltd |
Polypeptide antagonist
|
|
US7534595B2
(en)
*
|
2006-06-12 |
2009-05-19 |
Biomarin Pharmaceutical Inc. |
Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions thereof
|
|
US7531341B1
(en)
|
2006-06-12 |
2009-05-12 |
Biomarin Pharmaceutical Inc. |
Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions thereof
|
|
EP2044246A4
(en)
*
|
2006-07-06 |
2009-12-16 |
Molecular Logix Inc |
LIGAND DRUG DISCOVERY SYSTEM DOMINANT NEGATIVE
|
|
US9187532B2
(en)
|
2006-07-21 |
2015-11-17 |
Novo Nordisk A/S |
Glycosylation of peptides via O-linked glycosylation sequences
|
|
US20100075375A1
(en)
*
|
2006-10-03 |
2010-03-25 |
Novo Nordisk A/S |
Methods for the purification of polypeptide conjugates
|
|
CA2665480C
(en)
*
|
2006-10-04 |
2019-11-12 |
Novo Nordisk A/S |
Glycerol linked pegylated sugars and glycopeptides
|
|
WO2008073620A2
(en)
*
|
2006-11-02 |
2008-06-19 |
Neose Technologies, Inc. |
Manufacturing process for the production of polypeptides expressed in insect cell-lines
|
|
GB0622818D0
(en)
*
|
2006-11-15 |
2006-12-27 |
Jagotec Ag |
Improvements in or relating to organic compounds
|
|
EP2102355B1
(en)
|
2006-12-14 |
2016-03-02 |
Bolder Biotechnology, Inc. |
Long acting proteins and peptides and methods of making and using the same
|
|
GB0625303D0
(en)
*
|
2006-12-19 |
2007-01-24 |
Jagotec Ag |
Improvements in and relating to metered dose inhalers
|
|
WO2008092002A2
(en)
*
|
2007-01-24 |
2008-07-31 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing pancreatic cancer
|
|
CN101796063B
(zh)
|
2007-04-03 |
2017-03-22 |
拉蒂奥法姆有限责任公司 |
使用糖聚乙二醇化g‑csf的治疗方法
|
|
US20090053167A1
(en)
*
|
2007-05-14 |
2009-02-26 |
Neose Technologies, Inc. |
C-, S- and N-glycosylation of peptides
|
|
WO2008154639A2
(en)
|
2007-06-12 |
2008-12-18 |
Neose Technologies, Inc. |
Improved process for the production of nucleotide sugars
|
|
US7560263B2
(en)
|
2007-08-17 |
2009-07-14 |
Biomarin Pharmaceutical Inc. |
Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof
|
|
US8207112B2
(en)
|
2007-08-29 |
2012-06-26 |
Biogenerix Ag |
Liquid formulation of G-CSF conjugate
|
|
WO2009036349A1
(en)
*
|
2007-09-12 |
2009-03-19 |
Anaphore, Inc. |
Hsp70-based treatment for autoimmune diseases
|
|
GB0719818D0
(en)
*
|
2007-10-11 |
2007-11-21 |
Asterion Ltd |
Growth hormone fusion polypeptides
|
|
BRPI0818004B8
(pt)
|
2007-10-16 |
2021-05-25 |
Biocon Ltd |
composição farmacêutica sólida administrável por via oral e o processo da mesma.
|
|
CA2705160A1
(en)
*
|
2007-11-09 |
2009-05-14 |
Anaphore, Inc. |
Fusion proteins of mannose binding lectins for treatment of disease
|
|
US9938333B2
(en)
|
2008-02-08 |
2018-04-10 |
Ambrx, Inc. |
Modified leptin polypeptides and their uses
|
|
CN103497247A
(zh)
|
2008-02-27 |
2014-01-08 |
诺沃—诺迪斯克有限公司 |
缀合的因子viii分子
|
|
EP3412300A1
(en)
|
2008-06-27 |
2018-12-12 |
Duke University |
Therapeutic agents comprising elastin-like peptides
|
|
WO2010014225A2
(en)
|
2008-07-30 |
2010-02-04 |
Biomarin Pharmaceutical Inc. |
Assays for detection of phenylalanine ammonia-lyase and antibodies to phenylalanine ammonia-lyase
|
|
MX2011000847A
(es)
*
|
2008-08-06 |
2011-02-25 |
Novo Nordisk Healthcare Ag |
Proteinas conjugadas con eficacia prolongada in vivo.
|
|
ES2663536T3
(es)
|
2008-09-26 |
2018-04-13 |
Oncomed Pharmaceuticals, Inc. |
Agentes que se unen a receptores frizzled y usos de los mismos
|
|
EP2379585A2
(en)
|
2008-10-10 |
2011-10-26 |
Anaphore, Inc. |
Polypeptides that bind trail-ri and trail-r2
|
|
MX2011007736A
(es)
|
2009-01-22 |
2011-09-06 |
Novo Nordisk Healthcare Ag |
Compuestos de hormona del crecimiento estables.
|
|
SI2393828T1
(sl)
|
2009-02-03 |
2017-01-31 |
Amunix Operating Inc. |
Podaljšani rekombinantni polipetidi in sestavki, ki jih obsegajo
|
|
US8680050B2
(en)
|
2009-02-03 |
2014-03-25 |
Amunix Operating Inc. |
Growth hormone polypeptides fused to extended recombinant polypeptides and methods of making and using same
|
|
US8703717B2
(en)
|
2009-02-03 |
2014-04-22 |
Amunix Operating Inc. |
Growth hormone polypeptides and methods of making and using same
|
|
US9849188B2
(en)
|
2009-06-08 |
2017-12-26 |
Amunix Operating Inc. |
Growth hormone polypeptides and methods of making and using same
|
|
US8445953B2
(en)
*
|
2009-07-08 |
2013-05-21 |
Taiwan Semiconductor Manufacturing Company, Ltd. |
Structure for flash memory cells
|
|
WO2011015649A1
(en)
|
2009-08-06 |
2011-02-10 |
Novo Nordisk Health Care Ag |
Growth hormones with prolonged in-vivo efficacy
|
|
US20110086770A1
(en)
*
|
2009-10-09 |
2011-04-14 |
Anaphore, Inc. |
Combinatorial Libraries Based on C-type Lectin-like Domain
|
|
US20110086806A1
(en)
*
|
2009-10-09 |
2011-04-14 |
Anaphore, Inc. |
Polypeptides that Bind IL-23R
|
|
EP2332929A1
(en)
|
2009-11-25 |
2011-06-15 |
ArisGen SA |
Orthoester derivatives of crown ethers as carriers for pharmaceutical and diagnostic compositions
|
|
TWI535445B
(zh)
|
2010-01-12 |
2016-06-01 |
安可美德藥物股份有限公司 |
Ｗｎｔ拮抗劑及治療和篩選方法
|
|
CN118767117A
(zh)
|
2010-01-22 |
2024-10-15 |
诺沃—诺迪斯克保健股份有限公司 |
体内功效延长的生长激素
|
|
BR112012018162A2
(pt)
|
2010-01-22 |
2017-10-03 |
Novo Nordisk Healthcare Ag |
Compostos de hormônio do crescimento estáveis
|
|
ES2690542T3
(es)
|
2010-02-04 |
2018-11-21 |
Biomarin Pharmaceutical Inc. |
Método para purificar variantes de fenilalanina amoníaco-liasa procariotas
|
|
CN102971337B
(zh)
|
2010-04-01 |
2016-09-21 |
昂考梅德药品有限公司 |
卷曲蛋白结合药剂及其应用
|
|
US20130045215A1
(en)
|
2010-04-28 |
2013-02-21 |
University Of Southern California |
Growth hormone receptor deficiency causes a major reduction in pro-aging signaling, cancer and diabetes in humans
|
|
US20130143815A1
(en)
|
2010-07-22 |
2013-06-06 |
Novo Nordisk Health Care Ag |
Growth hormone conjugates
|
|
EP2446898A1
(en)
|
2010-09-30 |
2012-05-02 |
Laboratorios Del. Dr. Esteve, S.A. |
Use of growth hormone to enhance the immune response in immunosuppressed patients
|
|
WO2012151317A1
(en)
|
2011-05-03 |
2012-11-08 |
Genentech, Inc. |
Vascular disruption agents and uses thereof
|
|
EP2526971A1
(en)
|
2011-05-25 |
2012-11-28 |
ArisGen SA |
Mucosal delivery of drugs
|
|
WO2013113074A1
(en)
|
2012-02-03 |
2013-08-08 |
Antisense Therapeutics Ltd |
Combination therapy comprising a growth hormone variant and an oligonucleotide targeted to the growth hormone receptor
|
|
US10039813B2
(en)
|
2012-02-07 |
2018-08-07 |
Massachusetts Institute Of Technology |
Use of antagonists of ghrelin or ghrelin receptor to prevent or treat stress-sensitive psychiatric illness
|
|
HK1212216A1
(en)
|
2012-10-23 |
2016-06-10 |
Oncomed Pharmaceuticals, Inc. |
Methods of treating neuroendocrine tumors using wnt pathway-binding agents
|
|
JP2016510411A
(ja)
|
2013-02-04 |
2016-04-07 |
オンコメッド ファーマシューティカルズ インコーポレイテッド |
Ｗｎｔ経路インヒビターによる処置の方法およびモニタリング
|
|
WO2014139994A1
(en)
*
|
2013-03-11 |
2014-09-18 |
Novo Nordisk Health Care Ag |
Growth hormone compounds
|
|
CN105229035A
(zh)
*
|
2013-03-11 |
2016-01-06 |
诺和诺德保健股份有限公司 |
生长激素化合物
|
|
US9168300B2
(en)
|
2013-03-14 |
2015-10-27 |
Oncomed Pharmaceuticals, Inc. |
MET-binding agents and uses thereof
|
|
WO2014144231A1
(en)
|
2013-03-15 |
2014-09-18 |
Massachusetts Institute Of Technology |
Use of antagonists of growth hormone or growth hormone receptor to prevent or treat stress-sensitive psychiatric illness
|
|
CN105120887A
(zh)
|
2013-04-05 |
2015-12-02 |
诺和诺德保健股份有限公司 |
生长激素化合物制剂
|
|
CA2920666A1
(en)
|
2013-08-12 |
2015-02-19 |
Genentech, Inc. |
Compositions and method for treating complement-associated conditions
|
|
CR20160561A
(es)
|
2014-05-01 |
2017-05-03 |
Genentech Inc |
Variantes del anticuerpo anti-factor d y sus usos
|
|
CN104693433B
(zh)
*
|
2015-02-04 |
2017-06-06 |
国家纳米科学中心 |
一种聚乙二醇化氨磷汀、制备方法及其用途
|
|
WO2016138099A1
(en)
|
2015-02-24 |
2016-09-01 |
Massachusetts Institute Of Technology |
Use of ghrelin or functional ghrelin receptor agonists to prevent and treat stress-sensitive psychiatric illness
|
|
ES2784603T3
(es)
|
2015-06-02 |
2020-09-29 |
Novo Nordisk As |
Insulinas con extensiones recombinantes polares
|
|
EP3355931B1
(en)
|
2015-10-01 |
2024-06-26 |
Novo Nordisk A/S |
Protein conjugates
|
|
US10654932B2
(en)
|
2015-10-30 |
2020-05-19 |
Genentech, Inc. |
Anti-factor D antibody variant conjugates and uses thereof
|
|
US10407510B2
(en)
|
2015-10-30 |
2019-09-10 |
Genentech, Inc. |
Anti-factor D antibodies and conjugates
|
|
GB201520021D0
(en)
|
2015-11-13 |
2015-12-30 |
Asterion Ltd |
Fusion polypeptide
|
|
JP2020513019A
(ja)
|
2017-04-05 |
2020-04-30 |
ノヴォ ノルディスク アー／エス |
オリゴマー伸長インスリン−Ｆｃコンジュゲート
|
|
KR102167827B1
(ko)
*
|
2017-12-20 |
2020-10-20 |
주식회사 알테오젠 |
신규한 성장 호르몬 수용체 길항제 및 이의 융합 단백질
|
|
WO2019125002A1
(ko)
*
|
2017-12-20 |
2019-06-27 |
(주)알테오젠 |
신규한 성장 호르몬 수용체 길항제 및 이의 융합 단백질
|
|
WO2019211842A1
(en)
*
|
2018-04-30 |
2019-11-07 |
Opko Biologics Ltd. |
Long-acting human growth hormone-antagonists and methods of producing the same
|
|
CA3141128A1
(en)
*
|
2019-06-17 |
2020-12-24 |
Molecular Technologies Laboratories Llc |
Therapeutic pegylated growth hormone antagonists
|
|
US11999787B2
(en)
|
2020-03-24 |
2024-06-04 |
Genentech, Inc. |
Tie2-binding agents and methods of use
|
|
WO2023004687A1
(zh)
*
|
2021-07-29 |
2023-02-02 |
浙江新码生物医药有限公司 |
一种非天然氨基酸及其应用、包含其的重组蛋白以及重组蛋白偶联物
|
|
US20240317832A1
(en)
*
|
2021-07-29 |
2024-09-26 |
Novocodex Biopharmaceuticals Co., Ltd. |
Unnatural amino acid, and use thereof, recombinant protein containing same, and recombinant protein conjugate
|
|
AU2023314508A1
(en)
|
2022-07-29 |
2024-11-14 |
University Of Rochester |
Methods for improving muscle mass, strength, or function with a combination of testosterone and growth hormone
|
|
AU2024272220A1
(en)
|
2023-05-12 |
2025-10-16 |
Novo Nordisk A/S |
Long-acting growth hormone receptor antagonist and use thereof
|
|
KR20240172522A
(ko)
*
|
2023-06-01 |
2024-12-10 |
(주)알테오젠 |
지속형 호르몬 수용체 길항제의 생산 방법
|
|
WO2025259466A1
(en)
|
2024-06-13 |
2025-12-18 |
University Of Rochester |
Gm-csf and gm-csf-induced dendritic cells enhance fracture healing and bone repair
|